Among other key findings: More than half of employers that cover GLP-1s for weight management expect the expensive medications to yield significant clinical benefits, but few have seen evidence of those (e.g., a reduction in obesity rates, fewer employees needing bariatric surgery) within their aggregated claims
10.1016/j.biocel.2007.08.005 146 TianS.ChenM.WangB.HanY.ShangH.ChenJ
Alcohol also depletes the bodys fluids and can cause a person to feel thirst
ATTAIN-1 enrolled 3,127 adults with obesity or overweight who did not have type 2 diabetes
Also, a systematic review and meta-analysis found no significant difference in DR outcomes, including DR, macular edema, vitreous abnormality, requirement for eye-related surgery, and blindness, between SGLT2i and placebo users (risk ratio, 0.98
Avoid presenting symptom improvement as proof of tissue regeneration